MAZZANTI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 3.073
NA - Nord America 1.477
AS - Asia 807
AF - Africa 6
OC - Oceania 6
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.373
Nazione #
IT - Italia 2.246
US - Stati Uniti d'America 1.462
CN - Cina 661
IE - Irlanda 494
SG - Singapore 112
FI - Finlandia 98
DE - Germania 74
NL - Olanda 37
UA - Ucraina 23
GB - Regno Unito 21
SE - Svezia 20
FR - Francia 16
CA - Canada 15
IN - India 10
JP - Giappone 10
BE - Belgio 9
RU - Federazione Russa 9
PL - Polonia 6
AU - Australia 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
ES - Italia 3
GR - Grecia 3
TN - Tunisia 3
TR - Turchia 3
BD - Bangladesh 2
BR - Brasile 2
KW - Kuwait 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
PE - Perù 1
Totale 5.373
Città #
Dublin 492
Chandler 373
Milan 240
Nanjing 138
Rome 129
Boardman 118
Ashburn 117
Naples 86
Shanghai 86
Beijing 85
Princeton 74
San Genesio Ed Uniti 74
Singapore 74
Helsinki 71
Jacksonville 70
Lawrence 70
Medford 59
Turin 58
Wilmington 56
Changsha 51
Nanchang 51
Jiaxing 46
Hebei 44
Shenyang 42
Tianjin 37
Florence 31
Bologna 30
Hangzhou 27
Palermo 27
Genoa 25
New York 25
Ann Arbor 24
Bari 20
Padova 19
Parma 19
Brescia 17
Pavia 17
Woodbridge 17
Norwalk 16
Catania 15
Cagliari 14
Livorno 14
Toronto 13
Verona 12
Monserrato 11
Pisa 11
Seattle 11
London 10
Los Angeles 10
Pomigliano d'Arco 10
Brussels 9
Chicago 9
Imola 9
Messina 9
Trieste 9
Falls Church 8
Munich 8
Reggio Calabria 8
Baranzate 7
Spotorno 7
Venice 7
Ancona 6
Apiro 6
Banjara Hills 6
Bergamo 6
Catanzaro 6
Fairfield 6
Monza 6
Pescara 6
Decimomannu 5
Falkenstein 5
Fermo 5
Giugliano in Campania 5
Guanzate 5
Houston 5
Kobe 5
Lucca 5
Piscataway 5
Rovigo 5
Siena 5
Taranto 5
Tokyo 5
Washington 5
Zola Predosa 5
Afragola 4
Alba 4
Brno 4
Caivano 4
Cantù 4
Carate Brianza 4
Carbonia 4
Como 4
Fisciano 4
Macerata 4
Marsala 4
Modena 4
Montesilvano Marina 4
Osimo 4
San Francisco 4
Sassoferrato 4
Totale 3.463
Nome #
Sindrome di Brugada e idoneità alla mansione: case report 2.167
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 122
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 94
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 75
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 65
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 65
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 65
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 63
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 63
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 63
Genetic causes of sudden cardiac death in the young. 63
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 63
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 62
Brugada Syndrome: The Endless Conundrum 57
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 56
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 54
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 52
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 51
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 50
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 50
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 50
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 50
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 50
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 49
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 49
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 48
Usefulness of exercise test in the diagnosis of short QT syndrome 48
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 47
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 47
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 46
Genetic risk stratification in cardiac arrhythmias 45
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 44
The genetics of Long QT Syndrome 43
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 43
Diagnosis of Long QT Syndrome: Time to Stand Up! 42
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 41
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 40
Inherited arrhythmias: LQTS/SQTS/CPVT 37
Indications for genetic testing in athletes and its indication in clinical practice 37
Genetic Arrhythmias (Channelopathies) 36
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 35
Novel insights in the natural history of Short QT Syndrome 35
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 34
Is there a role for genetics in the prevention of sudden cardiac death? 34
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 34
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 34
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 33
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 33
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 32
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 32
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 32
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 32
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 30
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 29
Risk Stratification in the Long QT Syndrome 29
Dilated cardiomyopathy 29
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 29
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 29
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 28
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 28
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 28
Long-term follow-up of patients with short QT syndrome 28
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 28
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 28
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 27
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 27
Personalized therapies for cardiac channelopathies 27
Repeat adverse events long after percutaneous coronary revascularization in diabetics 27
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 27
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 25
Brugada syndrome and job fitness: report of three cases 24
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 24
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 23
Short QT syndromes 23
Brugada syndrome and job fitness: report of three cases 22
The interpretation of genetic tests in inherited cardiovascular diseases 20
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 19
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 19
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 19
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 18
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 18
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 18
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 16
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 14
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 13
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility 13
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 9
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 6
Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling 2
Totale 5.515
Categoria #
all - tutte 20.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020100 0 0 0 0 0 4 0 15 19 28 33 1
2020/2021184 10 19 1 5 0 17 6 39 58 17 9 3
2021/2022321 0 7 14 0 7 13 3 19 15 24 46 173
2022/20231.174 146 92 19 69 86 101 0 54 564 3 25 15
2023/20241.841 62 86 94 175 182 257 199 168 67 177 162 212
2024/20251.170 276 188 154 197 145 210 0 0 0 0 0 0
Totale 5.515